Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients

Publisher： Bentham Science Publishers

E-ISSN： 2212-3970|5|1|29-57

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.5, Iss.1, 2010-01, pp. : 29-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 931-939

Spandidos Publications

Access to resources Recommend Favorite

Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathway

By      

Oncology Reports, Vol. 33, Iss. 6, 2015-01 ,pp. : 3085-3092

Spandidos Publications

Access to resources Recommend Favorite

CD147 modulates autophagy through the PI3K/Akt/mTOR pathway in human prostate cancer PC-3 cells

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1439-1443

Spandidos Publications

Access to resources Recommend Favorite

miR125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway

By          

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 681-686

Spandidos Publications

Access to resources Recommend Favorite

A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: Correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features

By                      

Oncology Reports, Vol. 30, Iss. 2, 2013-01 ,pp. : 623-636

Spandidos Publications

Access to resources Recommend Favorite